Skip to search formSkip to main contentSkip to account menu

frovatriptan

Known as: 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, frovatriptan [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The early use of triptan in combination with a nonsteroidal anti-inflammatory drug after headache onset may improve the efficacy… 
Review
2011
Review
2011
The text presents a systematic approach to diagnosis, and is rich with expert recommendations for treating all types of headaches… 
Review
2011
Review
2011
Frovatriptan 2.5 mg has been investigated for the treatment of moderate or severe migraine attacks in six placebo-controlled… 
Review
2008
Review
2008
Frovatriptan is a 5-HT1B/1D receptor agonist that belongs to the triptan therapeutic class. Relative to other triptans… 
Review
2006
Review
2006
Triptan medications are selective serotonin receptor (5-HT1B/D) agonists approved for the treatment of acute migraine attacks… 
Review
2006
Review
2006
The discovery of the triptans (selective serotonin agonists 5HT1B/1D), with 7 compounds (almotriptan, eletriptan, frovatriptan… 
2003
2003
Volume 18, Issue 2 November 2002 
Review
2002
Review
2002
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2002
2002
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
1998
1998
The effects of frovatriptan (VML 251/SB-209509) on coronary artery function were investigated in isolated coronary arteries from…